Glycolytic diversity drives immune complexity in cancer

Area of Science:

• Oncology
• Immunology
• Metabolic studies

Background:

• The tumor immune microenvironment (TIME) is a key determinant of cancer progression and treatment response.
• Metabolic reprogramming, particularly glucose metabolism, significantly influences the TIME's composition and function.
• Understanding the interplay between cellular metabolism and immune responses within the tumor is crucial for developing effective cancer therapies.

Purpose of the Study:

• To review how glucose metabolism shapes the tumor immune microenvironment (TIME).
• To explore the impact of metabolic alterations on immune effector functions and immune evasion.
• To highlight therapeutic strategies targeting glucose metabolism for cancer treatment.

Main Methods:

• Literature review focusing on glucose metabolism and the tumor immune microenvironment.
• Analysis of studies investigating metabolic reprogramming in immune and tumor cells.
• Synthesis of current research on the influence of metabolic alterations on immune responses.

Main Results:

• Glucose metabolism dictates the cellular states of immune and tumor cells, thereby shaping the TIME.
• Glycolytic diversity in immune and tumor cells contributes to the complexity of the TIME.
• Metabolic alterations profoundly affect immune effector functions and promote immune evasion.

Conclusions:

• Glucose metabolism is a critical regulator of the tumor immune microenvironment.
• Modulating the TIME through metabolic interventions presents a promising therapeutic avenue.
• Targeting glucose metabolism in cancer therapies can enhance antitumor immunity and overcome immune evasion.